References
- Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652
- Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimized protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706–714
- Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eye drops for dry eyes an epithelial cell defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188–1197
- Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115–2220
- Phan TM, Foster CS, Boruchoff SA, Zagachin LM, Colvin RB. Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers. Am J Ophthalmol 1987;104:494–501
- Fredj-Reygrobellet D, Plouet J, Delayre T, Baudouin C, Bourret F, Lapalus P. Effects of aFGF and bFGF on wound healing in rabbit cornea. Current Eye Res 1987;6:1205–2309
- Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol 1999;83:390–395
- Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye disease. Cornea 2008;27:25–30
- Lee GA, Chen SX. Autologous serum in the management of recalcitrant dry eye syndrome. Clin Experiment Ophthalmol 2008;36:119–122
- Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology 1999;106:1984–1989
- Spessotto P, Dri P, Baschong W, Mittenzwei H, Patriarca P. Effect of protein-free dialysate from calf blood on human monocyte differentiation in vitro. Arzeimittelforschung 1993;43:747–751
- Egger SF, Huber-Spitzy V, Alzner E, Scholda C, Vecsei VP. Corneal wound healing after superficial foreign body injury: vitamin A and dexpanthenol versus a calf blood extract. Ophthalmologica 1999;213:246–249
- Studer O. A comparative clinical study of Solcoseryl® eye gel and cystein eye gel 2.4% in the treatment of foreign body injuries of the cornea. Ophthalmic Res 1984;16:179–184
- Kuniaka T, Senga Y, Senga H, Weiner M. Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract. J Cell Physiol 1991;146:148–155
- Lee JS, Kim EH, Kim SJ. Effects of calf serum on human corneal epithelial cells in vitro. J Korean Ophthalmol Soc 2012;52:852–858
- Gipson IK, Grill SM. A technique for obtaining sheets of intact rabbit corneal epithelium. Invest Opthahlmol Vis Sci 1982;23:269–273
- Mosmann TJ. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55–63
- Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificail tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459–461
- Eberle J, Habermann J, Gurtler LG. HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS 2000;14:206–207
- Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706–714